Stay updated on CIVO Intratumoral Microdosing Clinical Trial
Sign up to get notified when there's something new on the CIVO Intratumoral Microdosing Clinical Trial page.

Latest updates to the CIVO Intratumoral Microdosing Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer revision number changes from v3.7.2 to v3.8.0. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check24 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer site revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. This blocks access to the study details and shows the standard site header and footer around the error message.SummaryDifference20%

- Check52 days agoChange DetectedThe revision tag on the page updated from v3.6.6 to v3.7.0, indicating a new build of the site template. No study content or user-facing details appear to be altered by this update.SummaryDifference0.0%

Stay in the know with updates to CIVO Intratumoral Microdosing Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CIVO Intratumoral Microdosing Clinical Trial page.